Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 11.409
Filtrer
1.
Article de Anglais | MEDLINE | ID: mdl-39002926

RÉSUMÉ

BACKGROUND: Catatonia, as a transdiagnostic construct, manifests across various psychiatric and non-psychiatric conditions. Understanding how symptom variations impact the catatonia construct and differ across primary diagnoses (schizophrenia, bipolar disorder, unipolar depression, and neurological/metabolic/immunological condition) is essential to refine diagnostic and therapeutic approaches. This study aims to compare the symptom networks and centrality measures of these diagnoses. METHODS: We conducted a network analysis using Bush-Francis Catatonia Rating Scale (BFCRS) data from 118 patients, examining centrality measures and network comparisons across the four primary diagnostic groups. RESULTS: In the general catatonia network, the three most central symptoms identified were Excitement (1.462), Perseveration (1.456), and Impulsivity (1.332). While the overall structure of the catatonia networks did not show significant differences between diagnoses in terms of symptom connections and centrality, variations in centrality measures were observed among the different networks. CONCLUSIONS: The study reinforces the notion of catatonia as an independent syndrome relatively to psychiatric or non-psychiatric diagnoses. However, the variation in centrality of symptoms across different primary diagnoses provides critical insights that could aid clinicians in tailoring diagnostic and therapeutic strategies. Future research should further explore these relationships and develop more refined approaches to managing catatonia.


Sujet(s)
Catatonie , Catatonie/diagnostic , Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Trouble bipolaire/diagnostic , Échelles d'évaluation en psychiatrie , Jeune adulte , Schizophrénie/diagnostic , Schizophrénie/complications
3.
Sensors (Basel) ; 24(14)2024 Jul 20.
Article de Anglais | MEDLINE | ID: mdl-39066117

RÉSUMÉ

OBJECTIVE: The objective of this study is to explore and enhance the diagnostic process of unipolar and bipolar disorders. The primary focus is on leveraging automated processes to improve the accuracy and accessibility of diagnosis. The study aims to introduce an audio corpus collected from patients diagnosed with these disorders, annotated using the Clinical Global Impressions Scale (CGI) by psychiatrists. METHODS AND PROCEDURES: Traditional diagnostic methods rely on the clinician's expertise and consideration of co-existing mental disorders. However, this study proposes the implementation of automated processes in the diagnosis, providing quantitative measures and enabling prolonged observation of patients. The paper introduces a speech signal pipeline for CGI state classification, with a specific focus on selecting the most discriminative features. Acoustic features such as prosodies, MFCC, and LPC coefficients are examined in the study. The classification process utilizes common machine learning methods. RESULTS: The results of the study indicate promising outcomes for the automated diagnosis of bipolar and unipolar disorders using the proposed speech signal pipeline. The audio corpus annotated with CGI by psychiatrists achieved a classification accuracy of 95% for the two-class classification. For the four- and seven-class classifications, the results were 77.3% and 73%, respectively, demonstrating the potential of the developed method in distinguishing different states of the disorders.


Sujet(s)
Trouble bipolaire , Humains , Trouble bipolaire/diagnostic , Trouble bipolaire/physiopathologie , Femelle , Mâle , Parole/physiologie , Adulte , Apprentissage machine , Traitement du signal assisté par ordinateur , Adulte d'âge moyen , Diagnostic différentiel
5.
J Nerv Ment Dis ; 212(7): 398-402, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38949660

RÉSUMÉ

ABSTRACT: The DSM-III symptomatic criteria for major depression (MD) were derived from those proposed by Feighner and colleagues in 1972, which closely resembled those published by Cassidy in 1957. I here present a counter-factual history in which Feighner carefully read a key reference in Cassidy, a large 1953 follow-up study by Campbell of depressed patients with detailed tables of depressive signs and symptoms. In this alternative timeline, the Feighner criteria for MD were modified by Campbell's results, which then changed DSM-III and subsequent MD criteria sets. The historical pathway to the current DSM MD criteria was contingent on a range of historical events and could easily have been different. This story is not meant to criticize DSM MD criteria that perform well. Rather, it suggests that these criteria represent a useful but fallible set of symptoms/signs that index but do not constitute MD and therefore are not to be reified.


Sujet(s)
Trouble bipolaire , Trouble dépressif majeur , Diagnostic and stastistical manual of mental disorders (USA) , Humains , Trouble dépressif majeur/diagnostic , Trouble dépressif majeur/histoire , Histoire du 20ème siècle , Trouble bipolaire/histoire , Trouble bipolaire/diagnostic
6.
Cells ; 13(14)2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39056795

RÉSUMÉ

Increased immune-inflammatory activation has been repeatedly linked to etiopathogenesis and the progression of both major depressive disorder (MDD) and bipolar depression (BD). We explore the role of soluble intercellular cell adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) in diagnostic differentiation and disorder progression in patients with MDD and BD. Serum levels of sICAM-1 and sVCAM-1 were measured in 137 patients (MDD = 93 and BD = 44) and compared with 73 healthy controls. The severity of psychopathology was assessed using the Hamilton Depression Rating Scale and Clinical Global Impression Scale. After adjustment for multiple confounders, we noticed significant downregulation of sVCAM-1 and upregulation of sICAM-1 levels in both patient groups. Decreased sVCAM-1 levels were detected in patients with acute episodes of BD when compared to MDD. Immune mediators were related to indicators of progression in both mood disorders. They also followed different post-treatment normalization patterns in MDD and BD and in relation to the stage of each disorder. Adhesion molecules could potentially be useful in discriminating between patients with MDD and BD and determining the possible progression of the disorders. Future nosological methods should include time-dependent pathoplasticity and biological correlates, at least for affective disorders.


Sujet(s)
Trouble bipolaire , Molécule-1 d'adhérence intercellulaire , Molécule-1 d'adhérence des cellules vasculaires , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Marqueurs biologiques/sang , Trouble bipolaire/sang , Trouble bipolaire/diagnostic , Trouble bipolaire/immunologie , Études cas-témoins , Trouble dépressif majeur/sang , Trouble dépressif majeur/diagnostic , Diagnostic différentiel , Molécule-1 d'adhérence intercellulaire/sang , Molécule-1 d'adhérence des cellules vasculaires/sang
7.
Article de Russe | MEDLINE | ID: mdl-39072561

RÉSUMÉ

The study of cognitive impairment in bipolar disorder (BD) combined with anxiety-phobic disorders, as the most common comorbid pathology, is a new, little-studied and relevant direction for further research on BD, promising for clarifying the neurobiological mechanisms of the disease and improving the quality of the diagnostic process. By searching for combinations of the keywords «bipolar disorder¼, «anxiety disorders¼, «cognitive impairment¼, «cognitive dysfunction¼, «meta-analysis¼ and «review¼ in the databases «PubMed¼ and «Google Scholar¼, meta-analyses, analytical, review and original relevant research articles were identified. A generalization of the information accumulated in the literature indicates a) the presence in BD of both phase-dependent and persistent cognitive impairments that also occur during the period of euthymia, b) different structure and severity of neurocognitive disorders in cases of «pure¼ BD and anxiety-phobic disorders, c) the unique structure of cognitive impairment in BD with comorbid anxiety-phobic disorders, which incorporates the features of neurocognitive impairments that are characteristic of both disorders and have the greatest severity compared to them. The results of this review are of interest for planning further empirical studies of this topic on the Russian patient population.


Sujet(s)
Trouble bipolaire , Dysfonctionnement cognitif , Humains , Trouble bipolaire/complications , Trouble bipolaire/diagnostic , Dysfonctionnement cognitif/diagnostic , Dysfonctionnement cognitif/étiologie , Troubles anxieux/diagnostic , Troubles phobiques/diagnostic , Comorbidité
8.
BMC Psychiatry ; 24(1): 543, 2024 Jul 31.
Article de Anglais | MEDLINE | ID: mdl-39085797

RÉSUMÉ

BACKGROUND: Bipolar depression (BPD) is often misdiagnosed as a major depressive disorder (MDD) in clinical practice, which may be attributed to a lack of robust biomarkers indicative of differentiated diagnosis. This study analysed the differences in various hormones and inflammatory markers to explore peripheral biomarkers that differentiate BPD from MDD patients. METHODS: A total of 2,048 BPD and MDD patients were included. A panel of blood tests was performed to determine the levels of sex hormones, stress hormones, and immune-related indicators. Propensity score matching (PSM) was used to control for the effect of potential confounders between two groups and further a receiver operating characteristic (ROC) curve was used to analyse the potential biomarkers for differentiating BPD from MDD. RESULTS: Compared to patients with MDD, patients with BPD expressed a longer duration of illness, more hospitalisations within five years, and an earlier age of onset, along with fewer comorbid psychotic symptoms. In terms of biochemical parameters, MDD patients presented higher IgA and IgM levels, while BPD patients featured more elevated neutrophil and monocyte counts. ROC analysis suggested that combined biological indicators and clinical features could moderately distinguish between BPD and MDD. In addition, different biological features exist in BPD and MDD patients of different ages and sexes. CONCLUSIONS: Differential peripheral biological parameters were observed between BPD and MDD, which may be age-sex specific, and a combined diagnostic model that integrates clinical characteristics and biochemical indicators has a moderate accuracy in distinguishing BPD from MDD.


Sujet(s)
Marqueurs biologiques , Trouble bipolaire , Trouble dépressif majeur , Humains , Trouble bipolaire/sang , Trouble bipolaire/diagnostic , Trouble dépressif majeur/sang , Trouble dépressif majeur/diagnostic , Femelle , Mâle , Adulte , Marqueurs biologiques/sang , Diagnostic différentiel , Études rétrospectives , Adulte d'âge moyen , Jeune adulte
9.
Sci Rep ; 14(1): 13859, 2024 06 15.
Article de Anglais | MEDLINE | ID: mdl-38879556

RÉSUMÉ

Smooth pursuit eye movements are considered a well-established and quantifiable biomarker of sensorimotor function in psychosis research. Identifying psychotic syndromes on an individual level based on neurobiological markers is limited by heterogeneity and requires comprehensive external validation to avoid overestimation of prediction models. Here, we studied quantifiable sensorimotor measures derived from smooth pursuit eye movements in a large sample of psychosis probands (N = 674) and healthy controls (N = 305) using multivariate pattern analysis. Balanced accuracies of 64% for the prediction of psychosis status are in line with recent results from other large heterogenous psychiatric samples. They are confirmed by external validation in independent large samples including probands with (1) psychosis (N = 727) versus healthy controls (N = 292), (2) psychotic (N = 49) and non-psychotic bipolar disorder (N = 36), and (3) non-psychotic affective disorders (N = 119) and psychosis (N = 51) yielding accuracies of 65%, 66% and 58%, respectively, albeit slightly different psychosis syndromes. Our findings make a significant contribution to the identification of biologically defined profiles of heterogeneous psychosis syndromes on an individual level underlining the impact of sensorimotor dysfunction in psychosis.


Sujet(s)
Marqueurs biologiques , Troubles psychotiques , Poursuite oculaire , Humains , Mâle , Femelle , Poursuite oculaire/physiologie , Troubles psychotiques/diagnostic , Troubles psychotiques/physiopathologie , Adulte , Jeune adulte , Trouble bipolaire/diagnostic , Trouble bipolaire/physiopathologie , Adulte d'âge moyen , Études cas-témoins , Adolescent
11.
PLoS One ; 19(6): e0303699, 2024.
Article de Anglais | MEDLINE | ID: mdl-38905185

RÉSUMÉ

This study addresses the challenge of differentiating between bipolar disorder II (BD II) and borderline personality disorder (BPD), which is complicated by overlapping symptoms. To overcome this, a multimodal machine learning approach was employed, incorporating both electroencephalography (EEG) patterns and cognitive abnormalities for enhanced classification. Data were collected from 45 participants, including 20 with BD II and 25 with BPD. Analysis involved utilizing EEG signals and cognitive tests, specifically the Wisconsin Card Sorting Test and Integrated Cognitive Assessment. The k-nearest neighbors (KNN) algorithm achieved a balanced accuracy of 93%, with EEG features proving to be crucial, while cognitive features had a lesser impact. Despite the strengths, such as diverse model usage, it's important to note limitations, including a small sample size and reliance on DSM diagnoses. The study suggests that future research should explore multimodal data integration and employ advanced techniques to improve classification accuracy and gain a better understanding of the neurobiological distinctions between BD II and BPD.


Sujet(s)
Trouble bipolaire , Trouble de la personnalité limite , Électroencéphalographie , Apprentissage machine , Humains , Trouble de la personnalité limite/diagnostic , Trouble de la personnalité limite/physiopathologie , Trouble bipolaire/diagnostic , Trouble bipolaire/physiopathologie , Électroencéphalographie/méthodes , Adulte , Femelle , Mâle , Diagnostic différentiel , Jeune adulte , Cognition/physiologie , Algorithmes
12.
Sci Rep ; 14(1): 13434, 2024 06 11.
Article de Anglais | MEDLINE | ID: mdl-38862539

RÉSUMÉ

The recovery process in bipolar disorder is a subjective and multidimensional experience that seeks to develop new meanings and purposes for living a satisfying life despite the limitations imposed by the disorder. Thus, this qualitative study aimed to explore the perceptions of recovery and the meanings attributed by individuals undergoing treatment for bipolar disorder to the elements considered relevant in this process. Semi-structured interviews with open-ended questions were conducted to explore the experiences and perspectives of recovery in individuals undergoing treatment for bipolar disorder. Grounded Theory was used as the method for qualitative analysis. The study included 26 participants aged between 18 and 65 years. Based on the analysis of participant reports, we identified two main themes: living with the illness and what it means to be in recovery. The perception of recovery is an individual process and can differ from the medical model. Participants suggest that accepting the diagnosis of bipolar disorder and finding meaning in life are essential to their recovery. They also describe how mental health professionals can facilitate or hinder this process. Understanding patients' perceptions can facilitate access to healthcare services and treatment adherence.


Sujet(s)
Trouble bipolaire , Théorie ancrée , Humains , Trouble bipolaire/psychologie , Trouble bipolaire/diagnostic , Adulte , Femelle , Mâle , Adulte d'âge moyen , Adolescent , Sujet âgé , Jeune adulte , Recherche qualitative
13.
BMC Psychiatry ; 24(1): 450, 2024 Jun 18.
Article de Anglais | MEDLINE | ID: mdl-38890629

RÉSUMÉ

BACKGROUND: Bipolar Disorder is one of the most incapacitating diseases among young persons, leading to cognitive and functional impairment and raised mortality, particularly death by suicide. Managing a manic episode and developing new and more effective treatment modalities requires sensitive and reliable instruments. This study aims to translate the English version of the YMRS questionnaire into Kinyarwanda, adapt it to the Rwandan context, and assess its validity. METHODS: The original English version of The Young Mania Rating Scale questionnaire was translated into Kinyarwanda. The translation process followed a standardized approach, including back-translation, cross-cultural adaptation, and final adjustments. A total of 130 inpatients with bipolar disorder in a manic episode from CARAES Ndera Teaching Hospital were included. The descriptive statistics and test-retest correlations were carried out, as well as the CFA for validation and Rasch-analysis. RESULTS: The Rwandese version of The Young mania rating scale had an adequate internal consistency (Cronbach's alpha = 0.90). Item 11 provided the lowest standardized loading in both ratings (0.51 and 0.55). The second lowest loading involved the highly correlated item pairs 5 & 9, with item 5 loading 0.51 in rating 1 and item 9 loading 0.57 in rating 2. The remaining loadings ranged from 0.59 to 0.79. This relatively narrow range indicated that a fit to a Rasch model was plausible if excluding item 11. CONCLUSION: The findings demonstrate that the translated YMRS, the R-YMRS, can be used as a reliable and valid instrument for assessing mania in the Rwandese population in clinical and research settings. However, the results supported using an unweighted total score of 32 and removing items 5, 9, and 11. Studies on this revised scale with an added interview guide for less-trained clinical staff are recommended.


Sujet(s)
Trouble bipolaire , Échelles d'évaluation en psychiatrie , Psychométrie , Humains , Femelle , Mâle , Adulte , Trouble bipolaire/diagnostic , Trouble bipolaire/psychologie , Échelles d'évaluation en psychiatrie/normes , Reproductibilité des résultats , Manie/diagnostic , Jeune adulte , Indice de gravité de la maladie , Enquêtes et questionnaires/normes , Traductions , Adolescent
14.
BMJ Ment Health ; 27(1)2024 Jun 17.
Article de Anglais | MEDLINE | ID: mdl-38886095

RÉSUMÉ

BACKGROUND: Individuals with psychiatric disorders have an increased risk of developing dementia. Most cross-sectional studies suffer from selection bias, underdiagnosis and poor population representation, while there is only limited evidence from longitudinal studies on the role of anxiety, bipolar and psychotic disorders. Electronic health records (EHRs) permit large cohorts to be followed across the lifespan and include a wide range of diagnostic information. OBJECTIVE: To assess the association between four groups of psychiatric disorders (schizophrenia, bipolar disorder/mania, depression and anxiety) with dementia in two large population-based samples with EHR. METHODS: Using EHR on nearly 1 million adult individuals in Wales, and from 228 937 UK Biobank participants, we studied the relationships between schizophrenia, mania/bipolar disorder, depression, anxiety and subsequent risk of dementia. FINDINGS: In Secure Anonymised Information Linkage, there was a steep increase in the incidence of a first diagnosis of psychiatric disorder in the years prior to the diagnosis of dementia, reaching a peak in the year prior to dementia diagnosis for all psychiatric diagnoses. Psychiatric disorders, except anxiety, were highly significantly associated with a subsequent diagnosis of dementia: HRs=2.87, 2.80, 1.63 for schizophrenia, mania/bipolar disorder and depression, respectively. A similar pattern was found in the UK Biobank (HRs=4.46, 3.65, 2.39, respectively) and anxiety was also associated with dementia (HR=1.34). Increased risk of dementia was observed for all ages at onset of psychiatric diagnoses when these were divided into 10-year bins. CONCLUSIONS: Psychiatric disorders are associated with an increased risk of subsequent dementia, with a greater risk of more severe disorders. CLINICAL IMPLICATIONS: A late onset of psychiatric disorders should alert clinicians of possible incipient dementia.


Sujet(s)
Démence , Troubles mentaux , Humains , Démence/épidémiologie , Démence/étiologie , Démence/diagnostic , Femelle , Mâle , Adulte d'âge moyen , Sujet âgé , Adulte , Troubles mentaux/épidémiologie , Troubles mentaux/diagnostic , Pays de Galles/épidémiologie , Dossiers médicaux électroniques/statistiques et données numériques , Trouble bipolaire/épidémiologie , Trouble bipolaire/diagnostic , Royaume-Uni/épidémiologie , Schizophrénie/épidémiologie , Schizophrénie/diagnostic , Facteurs de risque , Sujet âgé de 80 ans ou plus , Incidence
15.
J Psychopathol Clin Sci ; 133(6): 456-468, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38829323

RÉSUMÉ

Bipolar disorder (BD) is a chronic psychiatric condition characterized by large episodic changes in mood and energy. Recently, BD has been proposed to be conceptualized as chronic cyclical mood instability, as opposed to the traditional view of alternating discrete episodes with stable periods in-between. Recognizing this mood instability may improve care and call for high-frequency measures coupled with advanced statistical models. To uncover empirically derived mood states, a multilevel hidden Markov model (HMM) was applied to 4-month ecological momentary assessment data in 20 patients with BD, yielding ∼9,820 assessments in total. Ecological momentary assessment data comprised self-report questionnaires (5 × daily) measuring manic and depressive constructs. Manic and depressive symptoms were also assessed weekly using the Altman Self-Rating Mania Scale and the Quick Inventory for Depressive Symptomatology Self-Report. Alignment between HMM-uncovered momentary mood states and weekly questionnaires was assessed with a multilevel linear model. HMM uncovered four mood states: neutral, elevated, mixed, and lowered, which aligned with weekly symptom scores. On average, patients remained < 25 hr in one state. In almost half of the patients, mood instability was observed. Switching between mood states, three patterns were identified: patients switching predominantly between (a) neutral and lowered states, (b) neutral and elevated states, and (c) mixed, elevated, and lowered states. In all, elevated and lowered mood states were interspersed by mixed states. The results indicate that chronic mood instability is a key feature of BD, even in "relatively" euthymic periods. This should be considered in theoretical and clinical conceptualizations of the disorder. (PsycInfo Database Record (c) 2024 APA, all rights reserved).


Sujet(s)
Affect , Trouble bipolaire , Évaluation écologique instantanée , Chaines de Markov , Humains , Trouble bipolaire/psychologie , Trouble bipolaire/diagnostic , Mâle , Femelle , Adulte , Adulte d'âge moyen , Autorapport , Études longitudinales , Dépression/psychologie , Dépression/épidémiologie , Manie/psychologie
16.
J Affect Disord ; 359: 269-276, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38795776

RÉSUMÉ

Changes in EEG have been reported in both major depressive disorder (MDD) and bipolar disorder (BD). Specifically, power changes in EEG alpha and theta frequency bands during rest and task are known in both disorders. This leaves open whether there are changes in yet another component of the electrophysiological EEG signal, namely phase-related processes that may allow for distinguishing MDD and BD. For that purpose, we investigate EEG-based spontaneous phase in the resting state of MDD, BD and healthy controls. Our main findings show: (i) decreased spontaneous phase variability in frontal theta of both MDD and BD compared to HC; (ii) decreased spontaneous phase variability in central-parietal alpha in MDD compared to both BD and HC; (iii) increased delays or lags of alpha phase cycles in MDD (but not in BD), which (iv) correlate with the decreased phase variability in MDD. Together, we show similar (decreased frontal theta variability) and distinct (decreased central-parietal alpha variability with increased lags or delays) findings in the spontaneous phase dynamics of MDD and BD. This suggests potential relevance of theta and alpha phase dynamics in distinguishing MDD and BD in clinical differential-diagnosis.


Sujet(s)
Rythme alpha , Trouble bipolaire , Trouble dépressif majeur , Électroencéphalographie , Lobe frontal , Rythme thêta , Humains , Trouble bipolaire/physiopathologie , Trouble bipolaire/diagnostic , Trouble dépressif majeur/physiopathologie , Trouble dépressif majeur/diagnostic , Adulte , Mâle , Femelle , Rythme thêta/physiologie , Rythme alpha/physiologie , Lobe frontal/physiopathologie , Diagnostic différentiel , Adulte d'âge moyen , Lobe pariétal/physiopathologie , Jeune adulte , Repos/physiologie , Cortex cérébral/physiopathologie
17.
Expert Rev Neurother ; 24(6): 565-574, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38753491

RÉSUMÉ

INTRODUCTION: The longitudinal course of bipolar disorder (BD) is associated with an active process of neuroprogression, characterized by structural brain alterations and progressive functional impairment. In the last decades, a growing need of a standardized staging model for BD arose, with the aim of a more appropriate definition of stage-specific clinical manifestations and the identification of more customized therapeutic tools. AREAS COVERED: The authors review the literature on clinical aspects, neurobiological correlates and treatment issues related to BD progression. Thereafter, they address the definition, constructs, and evolution of the staging concept, focusing on the clinical applications of BD staging models available in literature. EXPERT OPINION: Although several staging models for BD have been proposed to date, their application in clinical practice is still relatively scant. This may have a detrimental impact on the clinical and therapeutic management of BD, in terms of early and proper diagnosis as well as tailored treatment interventions according to the different stages of illness. Future research efforts should tend to the integration of recent insights on neuroimaging and epigenetic markers, toward a standardized and multidimensional staging model.


Sujet(s)
Trouble bipolaire , Évolution de la maladie , Trouble bipolaire/thérapie , Trouble bipolaire/diagnostic , Humains
18.
Arch Psychiatr Nurs ; 50: 94-99, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38789240

RÉSUMÉ

Children of people with a diagnosis of schizophrenia or bipolar disorder encounter great difficulties in coping with the symptoms of the disorders. The study was conducted to determine the feelings, opinions, life experiences, and needs of the children of parents with a diagnosis of schizophrenia or bipolar disorder. This is a descriptive study conducted using the in-depth interview design, a qualitative method. The sample consisted of 19 children who agreed to participate in the study with parental consent. Data were collected using a personal information form and a semi-structured qualitative interview form. The data were analyzed using the thematic analysis method. As a result of the thematic analysis, five main themes were obtained: Parents from children's eyes, living with parents, social pressure, coping strategies, this life with one word. The study concluded that children of parents followed up for schizophrenia or bipolar disorder struggle with many individual and social difficulties. These children have feelings of fear, embarrassment, or anger with this life experience; encounter social exclusion; and are overwhelmed with heavy responsibilities at an early age. Their coping strategies can be maladaptive, such as smoking or alcohol consumption, thinking of eloping, becoming introverted, and so on.


Sujet(s)
Adaptation psychologique , Trouble bipolaire , Enfant de personnes handicapées , Relations parent-enfant , Parents , Recherche qualitative , Schizophrénie , Humains , Trouble bipolaire/psychologie , Trouble bipolaire/diagnostic , Schizophrénie/diagnostic , Femelle , Mâle , Enfant , Enfant de personnes handicapées/psychologie , Parents/psychologie , Adolescent , Adulte , Entretiens comme sujet
19.
Geriatr Gerontol Int ; 24(6): 577-586, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38710639

RÉSUMÉ

AIM: To develop a typology of care trajectories (CTs) 1 year before and after a first dementia diagnosis in individuals aged ≥65 years, with prevalent schizophrenia or bipolar disorder. METHODS: This was a longitudinal, retrospective cohort study using health administrative data (1996-2016) from Quebec (Canada). We selected patients aged ≥65 years with an incident diagnosis of dementia between 1 January 2014 and 31 December 2016, and a diagnosis of schizophrenia and/or or bipolar disorder. A CT typology was generated by a multidimensional state sequence analysis based on the "6 W" model of CTs. Three dimensions were considered: the care setting ("where"), the reason for consultation ("why") and the specialty of care providers ("which"). RESULTS: In total, 3868 patients were categorized into seven distinct types of CTs, with varying patterns of healthcare use and comorbidities. Healthcare use differed in terms of intensity, but also in its distribution around the diagnosis. For instance, whereas one group showed low healthcare use, healthcare use abruptly increased or decreased after the diagnosis in other groups, or was equally distributed. Other significant differences between CTs included mortality rates and use of long-term care after the diagnosis. Most patients (67%) received their first dementia diagnosis during hospitalization. CONCLUSIONS: Our innovative approach provides a unique insight into the complex healthcare patterns of people living with serious mental illness and dementia, and provides an avenue to support data-driven decision-making by highlighting fragility areas in allocating care resources. Geriatr Gerontol Int 2024; 24: 577-586.


Sujet(s)
Démence , Humains , Démence/diagnostic , Démence/épidémiologie , Mâle , Femelle , Sujet âgé , Études rétrospectives , Québec/épidémiologie , Sujet âgé de 80 ans ou plus , Études longitudinales , Schizophrénie/diagnostic , Schizophrénie/épidémiologie , Trouble bipolaire/diagnostic , Trouble bipolaire/épidémiologie , Hospitalisation/statistiques et données numériques , Études de cohortes
20.
Nord J Psychiatry ; 78(5): 382-391, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38690774

RÉSUMÉ

BACKGROUND: The WHO Adult ADHD Self-report Scale (ASRSv1.1 and ASRS-S) is used for screening for attention-deficit/hyperactivity disorder (ADHD). The capacity of the Swedish version of the scale to discriminate ADHD from borderline personality disorder (BPD) and bipolar disorder (BP) has not been tested. AIM: Evaluate scoring methods, psychometric properties, and diagnostic accuracy of the Swedish versions of ASRSv1.1/ASRS-S in a group of patients with ADHD and/or BPD and/or BP. METHOD: A total of 151 young adult psychiatric patients diagnosed with ADHD, BPD and/or BD completed ASRSv1.1 and the Wender Utah Rating Scale (WURS) for ADHD symptoms, and the Sheehan Disability Scale (SDS) for functional impairment. ADHD diagnoses were assessed with the Schedule for Affective Disorders and Schizophrenia (K-SADS) interview. Both versions of the scale were analysed through dichotomised and non-dichotomised scoring for diagnostic accuracy analysis. RESULTS: The internal consistency for ASRSv1.1/ASRS-S was satisfactory with α 0.913 and 0.743, respectively. The two-factor structure of the ASRSv1.1 and the one factor structure of ASRS-S were supported by the confirmatory factor analyses. A strong positive correlation was found between ASRSv1.1 and WURS and a moderate level of correlation was found between ASRSv1.1 and SDS. The area under the curve for both scoring methods were excellent with an area under the curve (AUC) of 0.808 and 0.817, respectively. Optimal cut-off scores were in line with the original recommendations. CONCLUSION: The Swedish translation of ASRSv1.1/ASRS-S has psychometric properties comparable to other populations and the capacity to screen for ADHD in patients with overlapping symptoms.


Sujet(s)
Trouble déficitaire de l'attention avec hyperactivité , Trouble bipolaire , Trouble de la personnalité limite , Échelles d'évaluation en psychiatrie , Psychométrie , Autorapport , Humains , Trouble déficitaire de l'attention avec hyperactivité/diagnostic , Suède , Femelle , Adulte , Mâle , Trouble de la personnalité limite/diagnostic , Trouble bipolaire/diagnostic , Jeune adulte , Échelles d'évaluation en psychiatrie/normes , Reproductibilité des résultats , Diagnostic différentiel
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE